CD81 and neoplasm: In addition, CITE-seq analysis also showed an increase in CCL22 expression in CD81+migcDC1s upon Flt3L treatment and could together with the CCL22 expression observed in migDCs be the cause of the increased CCL22 observed in the E0771 tumor supernatants.